Irene Rivero-Calle
Overview
Explore the profile of Irene Rivero-Calle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
870
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borensztajn D, Zachariasse J, Carrol E, Nijman R, von Both U, Emonts M, et al.
BMC Pediatr
. 2025 Mar;
25(1):157.
PMID: 40025449
Background: Studies on procalcitonin (PCT) for identifying sepsis were published as early as 1993 and since then, PCT has been the topic of over 8,500 studies. Several studies show PCT...
2.
Viz-Lasheras S, Gomez-Carballa A, Pardo-Seco J, Bello X, Rivero-Calle I, Dacosta A, et al.
iScience
. 2025 Feb;
28(2):111747.
PMID: 39906557
Pneumonia stands as the primary cause of death among children under five, yet current diagnosis methods often result in inadequate or unnecessary treatments. Our research seeks to address this gap...
3.
Viz-Lasheras S, Gomez-Carballa A, Bello X, Rivero-Calle I, Dacosta A, Kaforou M, et al.
Nat Commun
. 2025 Jan;
16(1):673.
PMID: 39809748
Mycoplasma pneumoniae causes atypical pneumonia in children and young adults. Its lack of a cell wall makes it resistant to beta-lactams, which are the first-line treatment for typical pneumonia. Current...
4.
Kemps N, Vermont C, Tan C, von Both U, Carrol E, Emonts M, et al.
Arch Dis Child
. 2024 Sep;
110(3):191-196.
PMID: 39332842
Background: White blood cell count (WBC) is a widely used marker for the prediction of serious bacterial infection (SBI); however, previous research has shown poor performance. This study aims to...
5.
Pardo-Seco J, Viz-Lasheras S, Bello X, Gomez-Carballa A, Camino-Mera A, Pischedda S, et al.
Genes Dis
. 2024 Aug;
11(6):101170.
PMID: 39157457
No abstract available.
6.
Mallah N, Urbieta A, Rivero-Calle I, Gonzalez-Barcala F, Bigoni T, Papi A, et al.
Arch Bronconeumol
. 2024 Jun;
60(9):565-575.
PMID: 38876918
Chronic respiratory diseases (CRD) are responsible for more than four million deaths worldwide and have become especially prevalent in developed countries. Although the current therapies help manage daily symptoms and...
7.
Redondo E, Rivero-Calle I, Mascaros E, Ocana D, Jimeno I, Gil A, et al.
Arch Bronconeumol
. 2024 Jun;
60(8):541.
PMID: 38849274
No abstract available.
8.
Caballero-Gomez J, Pereira S, Rivero-Calle I, Perez A, Viciana I, Casares-Jimenez M, et al.
J Pediatr
. 2024 May;
273:114125.
PMID: 38815747
Two of 11 children with acute hepatitis of unknown origin were found to have rat hepatitis E virus infection. This infection should be considered in the differential diagnosis of children...
9.
Mallah N, Pardo-Seco J, Rivero-Calle I, Zhu-Huang O, Fernandez Prada M, Reynen-de Kat C, et al.
Hum Vaccin Immunother
. 2024 May;
20(1):2350817.
PMID: 38782400
COVID-19 vaccine uptake varied across countries, in part due to vaccine hesitancy fueled by a lack of trustworthy information. To help health workers provide evidence-based answers to common questions about...
10.
Mallah N, Ares-Gomez S, Pardo-Seco J, Malvar-Pintos A, Santiago-Perez M, Perez-Martinez O, et al.
Hum Vaccin Immunother
. 2024 May;
20(1):2348135.
PMID: 38738683
Nirsevimab has been recently licensed for universal RSV prophylaxis in infants. NIRSE-GAL is a three-year population-based study initiated in Galicia in September 2023. It aims to evaluate nirsevimab effectiveness against...